News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Dickran (Diko) Kazandjian: MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.
Photo of Dickran Kazandjian from umiamihealth.org
Sep 3, 2023, 05:14

Dickran (Diko) Kazandjian: MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.

Dickran (Diko) Kazandjian, a Professor of Medicine at the Sylvester Comprehensive Cancer Center and a Board Member of OncoDaily, shared on X/Twitter:

“MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Multiple Myeloma. Importantly, MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.”

For the original article click here.
For the editorial click here.
Source: Diko Kazandjian/Twitter

cancer CAR T-cell therapy Dikran Kazandjian Hematology multiple myeloma OncoDaily Oncology
Special Coverage
Dialogues
Jan 27, 2025, 05:00
BGICC25 Updates: Dr. Joseph Gligorov on Breast Cancer Advances
Blog
Jan 27, 2025, 04:55
Douglas Flora: As someone who's both treated cancer patients and survived cancer myself, I know first hand that progress can't afford to wait
Opinion
Jan 27, 2025, 04:40
5 articles suggested by Wafik El-Deiry
Science
Jan 26, 2025, 21:58
Nikolas Naleid: Excited to share our systematic review on pembrolizumab safety in GI cancers
Science
Jan 26, 2025, 21:58
David J. Benjamin: Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?
Science
Jan 26, 2025, 21:58
Fumiko Ladd Chino: Developing a simplified financial toxicity screening tool for use in clinical practice
Blog
Jan 26, 2025, 21:56
Wafaa M Rashed: Developing localized guidelines that reflect the continent's cultural, social and economic contexts
Blog
Jan 26, 2025, 21:56
Supriya Peshin: The most extraordinary team in GI oncology
Blog
Jan 26, 2025, 21:55
Razelle Kurzrock: Target Cancer National Molecular Tumor Board
Blog
Jan 26, 2025, 21:55
The current status of BCG and ways to accommodate the shortage
Blog
Jan 26, 2025, 21:55
Adjuvant chemotherapy vs Adjuvant CTRT in Gallbladder cancer
Blog
Jan 26, 2025, 21:55
Antonio D'Alessio: 9 year follow-up of adjuvant cell therapy for HCC at ASCOGI25